Study of adimanebart in healthy adults
This study tests how a single injection of adimanebart is absorbed by the body and how it travels through the bloodstream. It is for healthy adults to help understand the drug's behavior.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- For part 1 or 3: weigh between 60 and 100 kg with a body mass index (BMI) between 18.5 and 30. For part 2: weigh under 60 kg or between 100 and 130 kg with a BMI between 18.5 and 38.
- You must stop taking all prescription and over-the-counter medicines (except hormonal birth control or hormone replacement therapy) for at least 2 weeks before the study drug is given.
- You can take occasional acetaminophen (like Tylenol) or ibuprofen (like Advil) if needed.
- You have no current or past serious medical or psychiatric conditions, especially severe allergies to drugs or foods, that could affect the study results or your safety.
- You have not taken part in any other interventional clinical study or received an experimental medicine in the last 12 weeks or 5 half-lives (whichever is longer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of giving the drug efgartigimod under the skin in healthy adults. It helps ensure both methods work the same way, which may make treatment easier for patients in the future.
This trial tests a new medicine called ADB116 in healthy people to see how safe it is and how the body processes it. The results will help decide the right dose for future studies.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This is a first-in-human study testing the safety of an experimental drug called IMP761. It is an antibody that may affect the immune system. Healthy volunteers aged 18 to 55 can participate to help researchers learn about the drug's safety and how the body processes it.
This trial tests three similar drugs to see how they are processed by the body and how safe they are. It is for healthy volunteers to help find the best dose and form of these medications.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.